Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089
Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone[...]
04/29/2024 | Press release | Archived content
Please select the service you want to use:
Smartlinks | American Acquisition Opportunity Inc. | News | Environment | Conservation | Natural Resources | Climate Change | Company News | Business Announcement | Chemicals | Manufacturing | Shell Companies | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact